• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Multiple sclerosis and COVID-19: How could therapeutic scenarios change during the pandemic?

作者信息

Mantero Vittorio, Abate Lucia, Salmaggi Andrea, Cordano Christian

机构信息

Department of Neurology, MS Center, ASST Lecco, Lecco, Italy.

Department of Neurology, MS Center, ASST Lariana, Como, Italy.

出版信息

J Med Virol. 2021 Apr;93(4):1847-1849. doi: 10.1002/jmv.26796. Epub 2021 Jan 22.

DOI:10.1002/jmv.26796
PMID:33448419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8014825/
Abstract
摘要

相似文献

1
Multiple sclerosis and COVID-19: How could therapeutic scenarios change during the pandemic?多发性硬化症与2019冠状病毒病：大流行期间治疗方案可能如何变化？
J Med Virol. 2021 Apr;93(4):1847-1849. doi: 10.1002/jmv.26796. Epub 2021 Jan 22.
2
Multiple sclerosis and COVID-19.多发性硬化症与2019冠状病毒病
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Sep;164(3):217-225. doi: 10.5507/bp.2020.033. Epub 2020 Jul 17.
3
Treatment of multiple sclerosis under the COVID-19 pandemic.新冠疫情下的多发性硬化症治疗
Tidsskr Nor Laegeforen. 2020 Apr 29;140(8). doi: 10.4045/tidsskr.20.0333. Print 2020 May 26.
4
Management of Patients with Multiple Sclerosis During the COVID-19 Pandemics: A Portuguese Single-Centre Experience.2019冠状病毒病大流行期间多发性硬化症患者的管理：葡萄牙单中心经验
Acta Med Port. 2021 Feb 1;34(2):162. doi: 10.20344/amp.15187. Epub 2021 Jan 6.
5
Keeping standards of multiple sclerosis care through the COVID-19 pandemic.在新冠疫情期间维持多发性硬化症的护理标准。
Mult Scler. 2020 Sep;26(10):1153-1156. doi: 10.1177/1352458520931785. Epub 2020 Jun 19.
6
The COVID-19 pandemic and the use of MS disease-modifying therapies.新冠疫情与多发性硬化症疾病修正疗法的使用
Mult Scler Relat Disord. 2020 Apr;39:102073. doi: 10.1016/j.msard.2020.102073. Epub 2020 Mar 27.
7
Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic.COVID-19 大流行时期多发性硬化症患者的数字分诊。
Neurol Sci. 2020 May;41(5):1007-1009. doi: 10.1007/s10072-020-04391-9. Epub 2020 Apr 17.
8
Pandemic forward: Lessons learned and expert perspectives on multiple sclerosis care in the COVID-19 era.大流行展望：新冠疫情时代多发性硬化症护理的经验教训与专家观点
Mult Scler Relat Disord. 2021 Apr;49:102715. doi: 10.1016/j.msard.2020.102715. Epub 2020 Dec 24.
9
Multiple sclerosis following SARS-CoV-2 infection.感染 SARS-CoV-2 后出现多发性硬化症。
Mult Scler Relat Disord. 2020 Oct;45:102377. doi: 10.1016/j.msard.2020.102377. Epub 2020 Jul 7.
10
COVID-19 pandemic: The experience of a multiple sclerosis centre in Chile.新冠疫情：智利一家多发性硬化症中心的经历
Mult Scler Relat Disord. 2020 Jul;42:102204. doi: 10.1016/j.msard.2020.102204. Epub 2020 May 16.

引用本文的文献

1
SARS-CoV-2 infection in patients with neuroimmunological disorders in a tertiary referral centre from the north of Portugal.葡萄牙北部一家三级转诊中心的神经免疫性疾病患者中严重急性呼吸综合征冠状病毒 2 感染。
Mult Scler Relat Disord. 2022 Jul;63:103893. doi: 10.1016/j.msard.2022.103893. Epub 2022 May 16.
2
Multiple Sclerosis Patients and Disease Modifying Therapies: Impact on Immune Responses against COVID-19 and SARS-CoV-2 Vaccination.多发性硬化症患者与疾病修正疗法：对针对2019冠状病毒病和严重急性呼吸综合征冠状病毒2疫苗接种的免疫反应的影响
Vaccines (Basel). 2022 Feb 11;10(2):279. doi: 10.3390/vaccines10020279.

本文引用的文献

1
Impact of disease-modifying drugs on the severity of  COVID-19 infection in multiple sclerosis patients.疾病修正药物对多发性硬化症患者 COVID-19 感染严重程度的影响。
J Med Virol. 2021 Mar;93(3):1314-1319. doi: 10.1002/jmv.26593. Epub 2020 Oct 30.
2
Mild COVID-19 infection in a group of teriflunomide-treated patients with multiple sclerosis.一群接受特立氟胺治疗的多发性硬化症患者中的轻度新冠病毒感染。
J Neurol. 2021 Jun;268(6):2029-2030. doi: 10.1007/s00415-020-10196-9. Epub 2020 Aug 31.
3
Assessing the susceptibility to acute respiratory illness COVID-19-related in a cohort of multiple sclerosis patients.评估多发性硬化症患者队列中与 COVID-19 相关的急性呼吸道疾病易感性。
Mult Scler Relat Disord. 2020 Nov;46:102453. doi: 10.1016/j.msard.2020.102453. Epub 2020 Aug 19.
4
Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice. cladribine 治疗多发性硬化症的轻度或无 COVID-19 症状：两例病例及对临床实践的影响。
Mult Scler Relat Disord. 2020 Oct;45:102452. doi: 10.1016/j.msard.2020.102452. Epub 2020 Aug 16.
5
Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach.在新冠疫情期间管理多发性硬化症患者的疾病修正疗法和突破性活动：迈向优化方法
Ther Clin Risk Manag. 2020 Jul 22;16:651-662. doi: 10.2147/TCRM.S257714. eCollection 2020.
6
COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatment.新冠病毒肺炎在一名多发性硬化症患者中发作，该患者由于最近接受克拉屈滨治疗而出现严重的淋巴细胞减少症。
Mult Scler. 2020 Sep;26(10):1264-1266. doi: 10.1177/1352458520943783. Epub 2020 Aug 7.
7
COVID-19 and multiple sclerosis: A description of two cases on alemtuzumab.COVID-19 与多发性硬化症：两例阿仑单抗治疗病例描述。
Mult Scler Relat Disord. 2020 Oct;45:102402. doi: 10.1016/j.msard.2020.102402. Epub 2020 Jul 17.
8
Mild COVID-19 infection in a patient with multiple sclerosis and severe depletion of T-lymphocyte subsets due to alemtuzumab.一名患有多发性硬化症且因使用阿仑单抗导致T淋巴细胞亚群严重耗竭的患者发生轻度新型冠状病毒肺炎感染。
Mult Scler Relat Disord. 2020 Sep;44:102314. doi: 10.1016/j.msard.2020.102314. Epub 2020 Jun 20.
9
COVID-19 in dimethyl fumarate-treated patients with multiple sclerosis.富马酸二甲酯治疗的多发性硬化症患者中的新型冠状病毒肺炎
J Neurol. 2021 Jun;268(6):2023-2025. doi: 10.1007/s00415-020-10015-1. Epub 2020 Jun 25.
10
COVID-19 in persons with multiple sclerosis treated with ocrelizumab - A pharmacovigilance case series.接受奥瑞珠单抗治疗的多发性硬化症患者中的 COVID-19——一项药物警戒病例系列研究。
Mult Scler Relat Disord. 2020 Jul;42:102192. doi: 10.1016/j.msard.2020.102192. Epub 2020 May 16.